OBJECTIVES: To review long-term outcomes of patients with right atrial (RA) isomerism who underwent common atrioventricular valve (CAVV) plasty.
INTRODUCTION
Right atrial (RA) isomerism is a rare congenital heart disease [1] . Although the natural history of patients with RA isomerism, which has not been precisely reported, depends on associated cardiac structures or anomalies, Hashmi et al. reported that 21 of 22 patients (95%) who did not undergo planned cardiovascular surgical interventions died at a median age of 4 days [2] . Surgical intervention improves the outcome of RA isomerism, but the mortality rate of palliative surgery is high and the long-term outcome is unsatisfactory [2] [3] [4] . Several risk factors for mortality have been reported, such as totally anomalous pulmonary venous connection (TAPVC) repair, obstructed pulmonary veins, and neonatal surgical intervention [2] [3] [4] [5] . Additionally, atrioventricular valve regurgitation has been reported as one of the risk factors for mortality [2, 5] . Recently, atrioventricular valve plasty has been widely performed in patients with functional single ventricle (FSV) along with the diagnostic power of echocardiography and the repair technique, which have both improved [6] [7] [8] . However, very few patients in these reports underwent atrioventricular valve plasty before bidirectional cavopulmonary shunt (BCPS) [6] [7] [8] [9] . In addition, few reports have discussed CAVV plasty for patients with RA isomerism in detail [9] [10] .
We have also aggressively performed atrioventricular valve plasty using various techniques for patients with FSV, even before BCPS [10] [11] . Herein, we review the long-term outcome of patients with RA isomerism who have undergone CAVV plasty, and we focused on patients who underwent CAVV plasty in the neonatal period.
MATERIALS AND METHODS

Patient population
The present study was a single-centre retrospective analysis of medical records. The hospital's institutional review board approved this study, and informed consent for the study was waived. We reviewed 59 consecutive patients with RA isomerism who underwent their first operation (univentricular repair) between January 2004 and April 2016 at Mt. Fuji Shizuoka Children's Hospital. An additional 4 patients with RA isomerism were identified during this period, but they were excluded from the study; 2 of these patients had pulmonary venous atresia and their parents did not opt for surgical interventions, 1 died before the operation, and the other underwent biventricular repair. Patients' characteristics are shown in Table 1 .
Operation
First operation
The procedures for adjusting pulmonary blood flow during the first operation were the modified Blalock-Taussig shunt (MBTS) (33 patients) (with primary central pulmonary artery plasty [12] ), main pulmonary artery banding (8 patients), bilateral pulmonary artery banding (4 patients), BCPS (9 patients), and other procedures [5 patients; modified Blalock-Taussig shunt combined with pulmonary artery banding, central shunt, and major aortopulmonary collateral artery (MAPCA) banding (1 patient each); and isolated TAPVC repair (2 patients)] (Table 1) .
Totally anomalous pulmonary venous connection repair
Thirty-two patients had extracardiac TAPVC. TAPVC repair was performed in 34 patients. Twenty-five patients underwent TAPVC repair before BCPS. Our policy and surgical techniques of TAPVC repair have been previously reported [13] [14] .
Common atrioventricular valve plasty
Our criterion for CAVV plasty is more than moderate CAVV regurgitation. Twenty-nine patients underwent CAVV plasty (Table  2) . Ten patients underwent the first CAVV plasty during the first palliative surgery, and 3 patients underwent CAVV plasty between the first palliative surgery and BCPS. The age range at the first CAVV plasty was 2-824 days (median 23 days), and 7 patients were in the neonatal period. Sixteen patients underwent the first CAVV plasty with or after BCPS (BCPS, 7 patients; interstage between BCPS and total cavopulmonary connection [TCPC], 2 patients; TCPC, 6 patients; after TCPC, 1 patient). The age range at the first CAVV plasty was 92-1656 days (median 445 days). The types of atrioventricular connections were type A in 7 patients, type B in 9 and type C in 13 by Shizuoka-Children's Hospital Classification ( Fig. 1 ) [15] . The operative details have been previously reported [10, 11] . We used various techniques for CAVV plasty ( Table 2 ). The essentials of the inter-annular bridge technique, which we have used from 2007, have been described at a previous meeting [16] . The steps of the procedure are as follows: (i) trim the Gore-Tex patch (W. L. Gore & Associates, Inc., Naperville, IL, USA) to a 2-mm wide strip; (ii) estimate the annular fixed point (usually the centre position, which is the same as the main regurgitant point) by repeating the water injection test; (iii) suture one side of the strip to the posterior annulus, and determine the suture point of the anterior side using the water injection test; and (iv) after fixing both sides of the strip to the posterior and anterior annulus like a bridge, plicate the strip and reduce the width between the anterior-posterior annulus until valve regurgitation decreases, depending on the results of the water injection test (Fig. 2 ).
Outcome
First, we compared the overall survival and clinical course (rate of successfully performing BCPS and TCPC) between patients with CAVV plasty (CAVV plasty (+) group) and those without CAVV plasty (CAVV plasty (-) group). Second, in the subgroup analysis, we also compared the overall survival and clinical course (rate of successfully performing BCPS and TCPC) between patients who underwent the first CAVV plasty before BCPS (group before BCPS) and those who underwent the first CAVV plasty with or after BCPS (group with or after BCPS). The change in the degree of CAVV regurgitant between these 2 groups was also evaluated. The outcome of CAVV regurgitation of these 2 subgroups was also evaluated.
Statistical analysis
Data are presented as a mean ± standard deviation, range and median, or number and frequency as appropriate. Differences between groups were determined using the Fisher's exact test, v 2 test, or Student t-test as appropriate. Survival was estimated using the Kaplan-Meier method, and the log-rank test was used to make comparison between groups. P < 0.05 was considered statistically significant. All statistical analyses were performed using JMP, version 5.1 software (SAS Institute Inc., Cary, NC, USA).
RESULTS
With versus without common atrioventricular valve plasty
The patients' characteristics were not different between the 2 groups (Table 1) . Among 59 patients, 16 (27%) died; 7 patients were in the CAVV plasty (+) group, and 9 were in the CAVV plasty (-) group (P = 0.77). The causes of death in the CAVV plasty (+) group were chronic heart failure (2 patients), sudden death (2 patients), cyanosis, pulmonary venous stenosis and protein-losing enteropathy (each 1 patient). The causes of death in the CAVV plasty (-) group were the low cardiac output syndrome (2 patients), sudden death (2 patients), cyanosis, pulmonary high flow shock, shunt occlusion, septic shock, and shock during bronchoscopy (each 1 patient). The mean follow-up time was 5.0 ± 3.6 years in the CAVV plasty (+) group and 3.4 ± 3.3 years in the CAVV plasty (-) group (P = 0.08).
Respective Kaplan-Meier estimated survival rates at 1, 5 and 10 years were 89 ± 6%, 76 ± 9% and 70 ± 10% for the CAVV plasty (+) group and 77 ± 8%, 69 ± 9% and 69 ± 9% for the CAVV plasty (-) group (P = 0.45) (Fig. 3) . Twenty-three of 29 patients (79%) in the CAVV plasty (+) group and 21 of 30 (70%) in the CAVV plasty (-) group successfully underwent BCPS (P = 0.55). Eighteen patients (62%) in the CAVV plasty (+) group and 16 (53%) in the CAVV plasty (-) group underwent TCPC (P = 0.60). The percentages of end-diastolic volume (EDV) to normal subject before TCPC were 185 ± 48% in the CAVV plasty (+) group and 185 ± 53% in the CAVV plasty (-) group (P = 0.96) ( Table 1 ).
Before versus with or after the bidirectional cavopulmonary shunt operation
Respective Kaplan-Meier estimated survival rates at 1, 5 and 10 years were 70 ± 15%, 47 ± 17% and 47 ± 17% for the group before BCPS and 100 ± 0%, 93 ± 7% and 85 ± 10% for the group with or after BCPS (P = 0.01) (Fig. 4) . Seven patients (54%) in the group before BCPS underwent BCPS. Four patients (30%) in the group before BCPS and 14 (88%) in the group with or after BCPS underwent TCPC (P = 0.001) ( Table 2 ). Among 7 neonates, 4 including 3 recent patients are still alive; respective Kaplan-Meier estimated survival rates at 1, 5 and 10 years were 60 ± 20%, 30 ± 24% and 30 ± 24%. Only 2 (29%) patients underwent BCPS and 1 (14%) underwent TCPC.
Common atrioventricular valve regurgitation
The changes and latest CAVV regurgitation degrees are shown in Figs 5 and 6 , respectively. In the group before BCPS, 7 patients had severe regurgitation and 6 had moderate regurgitation before CAVV plasty. Seven patients underwent CAVV surgery more than twice. CAVV replacement was performed in 3 patients. One of these patients primarily underwent CAVV replacement during the neonatal period, because she had severe dysplastic CAVV, which was determined to be difficult to repair. CAVV plasty or CAVV replacement was performed 26 times in 13 patients. At the latest follow-up, 2 patients had moderate regurgitation, 4 had mild regurgitation and 2 patients were after valve replacement.
In the group with or after BCPS, 8 patients had severe regurgitation and 8 had moderate regurgitation before CAVV plasty. In this group, 13 patients underwent palliative surgery before BCPS. However, at the time of palliative surgery, all patients had less than mild CAVV regurgitation, except 1 patient. Three patients underwent CAVV plasty twice, and 2 underwent CAVV replacement after CAVV plasty. These 2 patients underwent repeat CAVV replacement because of a stuck valve. CAVV plasty or CAVV replacement was performed 24 times in 16 patients. At the latest follow-up, 5 patients had moderate regurgitation, 8 patients had mild regurgitation and 1 patient was after valve replacement. Of all 8 valve replacements, 7 were a mechanical valve (16 mm: 2.8 kg and 4.0 kg; 19 mm: 6.9 kg and 7.2 kg; 21 mm: 4.2 kg; 23 mm: 9.4 kg and 14.9 kg) and 1 was a bioprosthetic valve (21 mm: 14.9 kg).
DISCUSSION
In the present study, we found good long-term outcomes in patients who underwent CAVV plasty with or after BCPS; the 10-year survival rate was 85%. In addition to this result, the outcome of patients with CAVV plasty was as good as that of those without CAVV plasty. However, the outcome of patients who underwent CAVV plasty before BCPS, especially neonates, was still unacceptable. In the present discussion, we mainly focus on the following 2 points: (i) the good outcome of CAVV plasty with or after BCPS and (ii) unacceptable outcome of CAVV plasty in patients before BCPS including neonates, as well as anticipation of improving outcomes in this group of patients.
The reason why the outcome of CAVV plasty with or after BCPS can achieve 85% survival at 10 years may be associated with the progression of the diagnostic power of echocardiography and the effectiveness of valve repair techniques. As aforementioned regarding the recent echocardiographic evolution, Nii described the usefulness of 3D echocardiography. Three-dimensional echocardiography makes it possible to share the exact anatomy of the CAVV and mechanism of CAVV regurgitation between echocardiologists and surgeons preoperatively [15] . In the process, surgeons can obtain more distinct information about the CAVV and create a vivid image of CAVV plasty.
Concerning the surgical technique, some reports have shown the advantages of atrioventricular valve plasty for patients with FSV. Ando and Takahashi described the effectiveness of edge-to- In the before BCPS group, 7 of 13 patients underwent the first valve plasty during the neonatal period. Commissural annuloplasty was the main technique performed for both groups. Edge-to-edge repair was performed less frequently in the before BCPS group. The inter-annular bridge was used in both groups. We have been using this technique recently, so the number of patients was small. Overall mortality was not statistically different. The rate of performing BCPS and TCPC were significantly different. CAVV: common atrioventricular valve; BCPS: bidirectional cavopulmonary shunt; TCPC: total cavopulmonary connection.
edge repair for tricuspid valve or CAVV. They achieved a 95.5% rate of successful repair in the edge-to-edge group, and 77.3% of patients maintained mild regurgitation or less at a mean 2.6-year follow-up [17] . Honjo et al. [18] used various techniques according to the mechanism of valve regurgitation and achieved acceptable results. Our surgical strategies for CAVV regurgitation have been mentioned elsewhere [10, 11] . At the time of valve plasty, we make a supreme effort to reproduce the valve figure and regurgitation pattern examined using preoperative echocardiography under a beating heart condition during cardiac arrest. Although we used various conventional techniques such as circular annuloplasty, cleft closure, edge-to-edge repair and several adjusting techniques for abnormal subvalvular deformities, commissural annuloplasty is our current key technique to improve apposition of the adjoining leaflets and reduce the annular size. The advantages of this technique include maintaining growth capacity and enabling repeat repair without unnecessary reduction of the leaflet's annular base. Using these techniques, the outcomes of patients who underwent atrioventricular valve plasty have become reasonable [7-9, 17, 18] . Ando and Takahashi [17] reported an analysis of patients with FSV who underwent BCPS or TCPC, and the actual survival rates in the edge-to-edge group were 75.7% at 10 years and 60.5% at 20 years. In the Tront group, Kotani et al. reported that the 5-year freedom from death or transplant rate of patients with FSV who underwent atrioventricular plasty was 76.0%, and Honjo et al. [7, 18] reported that the 10-year freedom from death or transplant rate of patients who underwent successful atrioventricular plasty was 70%. In these reports, patients were mostly those who underwent atrioventricular valve plasty with or after BCPS. We also obtained a 70% survival at 10 years in the CAVV plasty (+) group, which is the same as the 69% survival rate in the CAVV plasty (-) group, and an 85% survival rate in group with or after BCPS. The percentage of EDV before TCPC in the CAVV plasty (+) group (185%) is the same as the percentage in the CAVV plasty (-) group in the present study, and is smaller than in patients with CAVV plasty before 2004 (273%, which we reported at a prior meeting in 2015, at the same time we reported 33% of 5-year survival [16] ). This may be related to the good results of the patients who underwent CAVV plasty.
In previous reports, the numbers of patients who underwent CAVV plasty before BCPS were small, mostly 2 or 3 patients each [7] [8] [9] 18] . Additionally, the information on neonates who underwent CAVV plasty was lacking due to the extremely limited numbers. For example, an annual report in Japan showed that there were only 2 neonates per year who underwent CAVV plasty Before CAVV plasty, 7 patients had severe regurgitation and 6 had moderate regurgitation. Second valve plasty was performed in 7 patients, and 3 of them underwent a third plasty and one replacement. One patient received a fourth plasty following replacement. Four patients died. CAVV: common atrioventricular valve; post: postoperatively; pre: preoperatively. [19] [20] . In our present study, 13 of 29 patients underwent CAVV plasty before BCPS, and of these, 7 were neonates.
The outcome of patients who underwent CAVV plasty before BCPS was poor, and it is unacceptable even now. When we started to treat early infants using conventional surgical techniques including edge-to-edge repair, we experienced torn leaflets which were difficult to repair due to the edge-to-edge suture. However, having gained experience in treating neonates and early infants, the edge-to-edge repair was used less frequently for two reasons: with experience with treating neonates and early infants increasing, we had to use edge-to-edge repair less frequently because of 2 reasons. First, long-lasting effective repair using an edge-to-edge suture is not easy in these patients because of special features of the leaflets, which are thin and fragile. The leaflets are easy to tear, and indeed, we experienced cutting of the leaflets despite very careful suturing. Second, sustainable repeat repair is difficult after edge-to-edge repair, and sometimes valve replacement is necessitated during reoperation. Thus, we now use commissural annuloplasty and the inter-annular bridge for these difficult patients to improve apposition without direct stitches on the thin leaflets. Commissural annuloplasty can provide better apposition between the adjoining leaflets, and the inter-annular bridge can contribute to improving apposition between the facing leaflets. These 2 procedures can reduce valve regurgitation without strongly restricting the leaflet's movement and leaving the chance of repeat repair [16] . In addition, most patients who underwent CAVV plasty before BCPS had the worst valve anatomy (abnormal subvalvar structures and leaflet dysplasia), and these abnormalities involve a complex mechanism of valve regurgitation. Severe tethering due to a short chorda (sometimes the leaflet attaches directly to the papillary muscle), small additional leaflets, and various clefts cause large and multiple deformities of the coaptation zone. The combination of commissural annuloplasty and the inter-annular bridge also seems suitable from the perspective of this mechanism. Actually, 3 recent patients (2 neonates and 1 early infant within 2 months afterbirth) in whom commissural annuloplasty and the inter-annular bridge were used are still alive; they are now 6 months (1 patient) and 1 year old (2 patients). The overall outcome of the patients who underwent CAVV plasty before BCPS is, indeed, still unacceptable, but our recent approach using commissural annuloplasty and intra-annular bridge is one of the potential approaches to improve the future outcome.
Our study had several limitations. It was retrospective, and the number of patients was small. Furthermore, the mean follow-up period was 4.2 ± 3.5 years. Thus a larger number of patients and longer follow-up are needed.
In summary, we achieved an acceptable result of 85% estimated survival at 10 years in patients who underwent CAVV plasty with or after BCPS by using several conventional techniques. As a result, we achieved almost the same survival in patients with CAVV plasty as that in those without CAVV plasty. However, treatment for patients who require CAVV plasty before BCPS, especially for neonates, is still challenging.
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